The Novo Nordisk Foundation discusses Danish vaccine production with government The Danish government and the Novo Nordisk Foundation are currently discussing the possibility of establishing vaccine production in Denmark, according to a Danish newspaper. Photo: Jens Dresling BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN Published: 15.03.21 at 15:14 The Novo Nordisk Foundation and the Danish government currently have a dialog going on the possibility of establishing vaccine production on Danish soil, according to Danish newspaper Berlingske. Already a subscriber? Log in. Read the whole article Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial. Access all locked articles Receive our daily newsletters Access our app First name: Last name: E-mail address: Password: I accept the terms and conditions An error has occured. Please try again later. Create trial Get full access for you and your coworkers. Start a free company trial today More from MedWatch EU Commission proposes staggered transition to new medtech requirements after industry warnings After criticism for a lack of clarity on the regulation for medtech devices from doctors and industry players, the EU Commission has proposed an extension of the transition period. New majority owner makes several board appointments at hearing firm Eargo’s new majority shareholder, Patient Square Capital, is now represented by several board members. Danish agency joins competition authority chorus in criticizing Oticon Medical sale The Danish competition authorities are the latest to express concern over the potential sale of Demant’s Oticon Medical division to Cochlear. Full house for Ambu – all products live up to new EU requirements Medtech company Ambu can boast that all of its products live up to the MDR directive, which has introduced stricter requirements for medical equipment. FDA approves new sensor for insulin pens A new type of sensor which is able to collect and transmit key treatment information has been approved by the FDA. Print Print Increase text size Increase text size Decrease text size Decrease text size Further reading USD 1.6bn investment to ensure supplies of sought-after Novo Nordisk drug Danish agency joins competition authority chorus in criticizing Oticon Medical sale EU Commission proposes staggered transition to new medtech requirements after industry warnings Ambu CEO heralds transition year after "too optimistic" past predictions New majority owner makes several board appointments at hearing firm Related articles Danish government hesitant to rein in EU health response even though industry calls for it Novo Nordisk EVP: "When you're the little brother you're still part of the family. This is important to remember" Novo Nordisk chairman on lacking diversity: "I haven't done enough"